榮豐控股(000668.SZ)擬向控股股東出售安徽威宇33.74%股權 剝離醫療健康資產、迴歸房地產開發與銷售主業
格隆匯2月20日丨榮豐控股(000668.SZ)披露重大資產重組預案,2023年2月18日,公司與控股股東盛世達簽署了《盛世達投資有限公司與榮豐控股集團股份有限公司關於安徽威宇醫療器械科技有限公司之附條件生效股權轉讓協議》,擬通過現金出售的方式向盛世達出售公司持有的安徽威宇33.74%股權。此次交易公司通過出售安徽威宇股權及收到的業績承諾補償款合計將不低於3.77億元。
此次交易完成後,公司不再持有安徽威宇股權。此次交易完成後,公司將剝離安徽威宇,迴歸房地產開發與銷售的主營業務。同時,通過此次重大資產出售,公司能夠收回部分現金,有利於減輕公司經營壓力,改善自身業務結構和經營狀況。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.